Laforin/EPM2A Antibody (S84-37) Summary
| Immunogen |
Fusion protein amino acids 1-331 (full-length) of human Laforin.
|
| Localization |
Endoplasmic Reticulum
|
| Specificity |
Detects approx 40kDa.
|
| Predicted Species |
Rat (90%). Backed by our 100% Guarantee.
|
| Isotype |
IgG1
|
| Clonality |
Monoclonal
|
| Host |
Mouse
|
| Gene |
EPM2A
|
| Purity |
Protein G purified
|
| Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
| Dilutions |
|
| Application Notes |
1 ug/ml of Laforin Antibody was sufficient for detection of Laforin in 20 ug of human brain lysate by colorimetric immunoblot analysis using Goat anti-mouse IgG:HRP as the secondary Antibody.
|
Packaging, Storage & Formulations
| Storage |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
|
| Buffer |
PBS (pH 7.4) and 50% Glycerol
|
| Preservative |
0.1% Sodium Azide
|
| Concentration |
1 mg/ml
|
| Purity |
Protein G purified
|
Alternate Names for Laforin/EPM2A Antibody (S84-37)
- EC 3.1.3.16
- EC 3.1.3.48
- epilepsy, progressive myoclonus type 2, Lafora disease (laforin)
- epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
- EPM2
- EPM2A
- Lafora PTPase
- Laforin
- LAFPTPase
- LD
- LDE
- MELF
